3
|
Brinson RG, Marino JP, Delaglio F, Arbogast LW, Evans RM, Kearsley A, Gingras G, Ghasriani H, Aubin Y, Pierens GK, Jia X, Mobli M, Grant HG, Keizer DW, Schweimer K, Ståhle J, Widmalm G, Zartler ER, Lawrence CW, Reardon PN, Cort JR, Xu P, Ni F, Yanaka S, Kato K, Parnham SR, Tsao D, Blomgren A, Rundlöf T, Trieloff N, Schmieder P, Ross A, Skidmore K, Chen K, Keire D, Freedberg DI, Suter-Stahel T, Wider G, Ilc G, Plavec J, Bradley SA, Baldisseri DM, Sforça ML, Zeri ACDM, Wei JY, Szabo CM, Amezcua CA, Jordan JB, Wikström M. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics. MAbs 2018; 11:94-105. [PMID: 30570405 PMCID: PMC6343768 DOI: 10.1080/19420862.2018.1544454] [Citation(s) in RCA: 61] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
The increased interest in using monoclonal antibodies (mAbs) as a platform for biopharmaceuticals has led to the need for new analytical techniques that can precisely assess physicochemical properties of these large and very complex drugs for the purpose of correctly identifying quality attributes (QA). One QA, higher order structure (HOS), is unique to biopharmaceuticals and essential for establishing consistency in biopharmaceutical manufacturing, detecting process-related variations from manufacturing changes and establishing comparability between biologic products. To address this measurement challenge, two-dimensional nuclear magnetic resonance spectroscopy (2D-NMR) methods were introduced that allow for the precise atomic-level comparison of the HOS between two proteins, including mAbs. Here, an inter-laboratory comparison involving 26 industrial, government and academic laboratories worldwide was performed as a benchmark using the NISTmAb, from the National Institute of Standards and Technology (NIST), to facilitate the translation of the 2D-NMR method into routine use for biopharmaceutical product development. Two-dimensional 1H,15N and 1H,13C NMR spectra were acquired with harmonized experimental protocols on the unlabeled Fab domain and a uniformly enriched-15N, 20%-13C-enriched system suitability sample derived from the NISTmAb. Chemometric analyses from over 400 spectral maps acquired on 39 different NMR spectrometers ranging from 500 MHz to 900 MHz demonstrate spectral fingerprints that are fit-for-purpose for the assessment of HOS. The 2D-NMR method is shown to provide the measurement reliability needed to move the technique from an emerging technology to a harmonized, routine measurement that can be generally applied with great confidence to high precision assessments of the HOS of mAb-based biotherapeutics.
Collapse
Affiliation(s)
- Robert G Brinson
- a Institute of Bioscience and Biotechnology Research , National Institute of Standards and Technology and the University of Maryland , Rockville , MD , USA
| | - John P Marino
- a Institute of Bioscience and Biotechnology Research , National Institute of Standards and Technology and the University of Maryland , Rockville , MD , USA
| | - Frank Delaglio
- a Institute of Bioscience and Biotechnology Research , National Institute of Standards and Technology and the University of Maryland , Rockville , MD , USA
| | - Luke W Arbogast
- a Institute of Bioscience and Biotechnology Research , National Institute of Standards and Technology and the University of Maryland , Rockville , MD , USA
| | - Ryan M Evans
- b Applied and Computational Mathematics Division , National Institute of Standards and Technology , Gaithersburg , MD , USA
| | - Anthony Kearsley
- b Applied and Computational Mathematics Division , National Institute of Standards and Technology , Gaithersburg , MD , USA
| | - Geneviève Gingras
- c Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate , Health Canada , Ottawa , ON , Canada
| | - Houman Ghasriani
- c Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate , Health Canada , Ottawa , ON , Canada
| | - Yves Aubin
- c Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate , Health Canada , Ottawa , ON , Canada
| | - Gregory K Pierens
- d The Centre for Advanced Imaging , The University of Queensland , St Lucia , QLD , Australia
| | - Xinying Jia
- d The Centre for Advanced Imaging , The University of Queensland , St Lucia , QLD , Australia
| | - Mehdi Mobli
- d The Centre for Advanced Imaging , The University of Queensland , St Lucia , QLD , Australia
| | - Hamish G Grant
- e Bio21 Molecular Science & Biotechnology Institute , The University of Melbourne , Victoria , Australia
| | - David W Keizer
- e Bio21 Molecular Science & Biotechnology Institute , The University of Melbourne , Victoria , Australia
| | | | - Jonas Ståhle
- g Department of Organic Chemistry , Arrhenius Laboratory, Stockholm University , Stockholm , Sweden
| | - Göran Widmalm
- g Department of Organic Chemistry , Arrhenius Laboratory, Stockholm University , Stockholm , Sweden
| | - Edward R Zartler
- h Analytical R&D , Pfizer Essential Health , Lake Forest , IL , USA
| | - Chad W Lawrence
- i Pacific Northwest National Laboratory , Earth and Biological Sciences Directorate , Richland , DC , USA
| | - Patrick N Reardon
- i Pacific Northwest National Laboratory , Earth and Biological Sciences Directorate , Richland , DC , USA
| | - John R Cort
- i Pacific Northwest National Laboratory , Earth and Biological Sciences Directorate , Richland , DC , USA
| | - Ping Xu
- j Department of Downstream Processing and Analytics , Human Health Therapeutics Research Centre, National Research Council of Canada , Montreal , Quebec , Canada
| | - Feng Ni
- j Department of Downstream Processing and Analytics , Human Health Therapeutics Research Centre, National Research Council of Canada , Montreal , Quebec , Canada
| | - Saeko Yanaka
- k Institute for Molecular Science and Exploratory Research Center on Life and Living Systems , National Institutes of Natural Sciences , Myodaiji, Okazaki , Japan
| | - Koichi Kato
- k Institute for Molecular Science and Exploratory Research Center on Life and Living Systems , National Institutes of Natural Sciences , Myodaiji, Okazaki , Japan
| | - Stuart R Parnham
- l Department of Biochemistry and Molecular Biology , Medical University of South Carolina , Charleston , SC , USA
| | - Desiree Tsao
- m Analytical Development , Momenta Pharmaceuticals , Cambridge , MA , USA
| | - Andreas Blomgren
- n Laboratory Unit , Swedish Medical Products Agency, Laboratory , Uppsala , Sweden
| | - Torgny Rundlöf
- n Laboratory Unit , Swedish Medical Products Agency, Laboratory , Uppsala , Sweden
| | - Nils Trieloff
- o NMR-supported Structural Biology , Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Berlin , Germany
| | - Peter Schmieder
- o NMR-supported Structural Biology , Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Berlin , Germany
| | - Alfred Ross
- p Roche Pharmaceutical Research & Early Development , Pre-Clinical CMC, Roche Innovation Center Basel , Basel , Switzerland
| | - Ken Skidmore
- q Analytical Operations , Genentech , South San Francisco , CA , USA
| | - Kang Chen
- r Center for Drug Evaluation and Research , Food and Drug Administration , Maryland , USA
| | - David Keire
- r Center for Drug Evaluation and Research , Food and Drug Administration , Maryland , USA
| | - Darón I Freedberg
- s Center for Biologics Evaluation and Research , Food and Drug Administration , Maryland , USA
| | - Thea Suter-Stahel
- t Department of Biology , Institute of Molecular Biology and Biophysics , ETH Zurich, Zurich , Switzerland
| | - Gerhard Wider
- t Department of Biology , Institute of Molecular Biology and Biophysics , ETH Zurich, Zurich , Switzerland
| | - Gregor Ilc
- u NMR Centre , EN-FIST Centre of Excellence , Ljubljana , Slovenia.,v NMR Centre , National Institute of Chemistry , Ljubljana , Slovenia
| | - Janez Plavec
- u NMR Centre , EN-FIST Centre of Excellence , Ljubljana , Slovenia.,v NMR Centre , National Institute of Chemistry , Ljubljana , Slovenia
| | - Scott A Bradley
- w Eli Lilly and Company , Lilly Corporate Center , Indianapolis , IN , USA
| | - Donna M Baldisseri
- x MRS - Application Science , Bruker BioSpin Corporation , Billerica , MA , USA
| | - Mauricio Luis Sforça
- y Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM) , Campinas, Brazil
| | - Ana Carolina de Mattos Zeri
- z Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM) , Campinas, Brazil , CEP
| | - Julie Yu Wei
- aa Protein Product Development , Biogen Inc ., Cambridge , MA , USA
| | - Christina M Szabo
- ab Baxter Pharmaceuticals R&D , Baxter Healthcare , Round Lake, IL , USA
| | - Carlos A Amezcua
- ab Baxter Pharmaceuticals R&D , Baxter Healthcare , Round Lake, IL , USA
| | - John B Jordan
- ac Global Regulatory and R&D Policy , Amgen Inc ., Thousand Oaks , CA , USA
| | - Mats Wikström
- ad Higher Order Structure, Attribute Sciences , Amgen Inc ., Thousand Oaks , CA , USA
| |
Collapse
|